US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProKidney Corp.

2.08

-0.1300-5.88%

Volume:1.33M

Turnover:2.82M

Market Cap:625.74M

PE:-3.83

High:2.21

Open:2.21

Low:2.06

Close:2.21

52wk High:7.13

52wk Low:0.4603

Shares:300.83M

Float Shares:274.16M

Volume Ratio:1.32

T/O Rate:0.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5433

EPS(LYR):-0.6249

ROE:-41.81%

ROA:-25.85%

PB:-0.62

PE(LYR):-3.33

Loading ...

Overview Company News Filings

ProKidney Corp. Director Brian JG Pereira Reports Sale of Common Shares

ProKidney Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $217.000K Beat $44.250K Estimate

ProKidney reports Q3 2025 results and updates on Phase 3 CKD therapy trial

ProKidney: Q3 Net Loss per Share Attributable to Class a Stock $0.12

THOMSON REUTERS

Press Release: ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Prokidney Corp expected to post a loss of 13 cents a share - Earnings Preview

ProKidney Announces Phase 3 Trial Progress for Rilparencel in Advanced CKD and Diabetes

ProKidney Presents Full Results From the Phase 2 Regen-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

THOMSON REUTERS

ProKidney Corp. to Join Guggenheim Healthcare Innovation Conference

BRIEF-Prokidney Corp to sell Greensboro property for $19.1 million - SEC filing

ProKidney Corp - to Sell Greensboro Property for $19.1 Mln - SEC Filing

THOMSON REUTERS

Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks

Simply Wall St.

SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC

Benzinga_recent_news

ProKidney Leads Our Trio Of Promising Penny Stocks

Simply Wall St.

ProKidney Corp. to Participate in Citi Biopharma Back to School and Morgan Stanley Global Healthcare Conferences

ProKidney Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $221.000K

ProKidney Announces Positive Phase 2 REGEN-007 Results and FDA Alignment for Accelerated Approval Pathway of Rilparencel

UBS Adjusts ProKidney Price Target to $8 From $4, Maintains Buy Rating

MT Newswires Live

BRIEF-Prokidney Announces Alignment With The FDA On The Accelerated Approval Pathway For Rilparencel

ProKidney Corp. Secures FDA Alignment for Accelerated Approval Pathway of Rilparencel in Advanced CKD and Type 2 Diabetes

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PROK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PROK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PROK\",,,,,undefined,":{"symbol":"PROK","market":"US","secType":"STK","nameCN":"ProKidney Corp.","latestPrice":2.08,"timestamp":1765832400000,"preClose":2.21,"halted":0,"volume":1334619,"delay":0,"floatShares":274159714,"shares":300834400,"eps":-0.543298,"marketStatus":"Pre-Mkt","change":-0.13,"latestTime":"12-16 05:26:37 EST","open":2.21,"high":2.21,"low":2.06,"amount":2819070.336654,"amplitude":0.067873,"askPrice":2.3,"askSize":100,"bidPrice":1.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.543298,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765895400000},"marketStatusCode":1,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":2.08,"postHourTrading":{"tag":"盘后","latestPrice":2.1,"preClose":2.08,"latestTime":"19:18 EST","volume":6866,"amount":14540.4482,"timestamp":1765844308744},"volumeRatio":1.3152519157250833,"impliedVol":4.4197,"impliedVolPercentile":1},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PROK\",,,,,undefined,":{"symbol":"PROK","floatShares":274159714,"roa":"-25.85%","roe":"-41.81%","lyrEps":-0.624881,"volumeRatio":1.3152519157250833,"shares":300834400,"dividePrice":0,"high":2.21,"amplitude":0.067873,"preClose":2.21,"low":2.06,"week52Low":0.4603,"pbRate":"-0.62","psRate":"841.04","week52High":7.13,"institutionHeld":0,"latestPrice":2.08,"eps":-0.543298,"divideRate":0,"volume":1334619,"delay":0,"ttmEps":-0.543298,"open":2.21,"prevYearClose":1.69,"prevWeekClose":2.21,"prevMonthClose":2.22,"prevQuarterClose":2.42,"fiveDayClose":2.35,"twentyDayClose":2.41,"sixtyDayClose":2.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PROK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"PROK","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-08-12","symbol":"PROK","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-05-12","symbol":"PROK","fiscalQuarterEnding":"2025/03","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2025-03-17","symbol":"PROK","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2024-11-12","symbol":"PROK","fiscalQuarterEnding":"2024/09","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PROK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PROK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.125,"hold":0.375,"sell":0.125,"strongSell":0,"meanLabel":"BUY","meanPercent":0.125,"analysts":8,"updateTime":1755147600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PROK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PROK","date":"2025-12-15","current":-3.82847,"percent":0.62763,"low":-81.837258,"twenty":-19.533266,"median":-5.684523,"eighty":-3.907792,"high":-0.634931,"avg":-11.90334,"sd":14.240588,"marketCap":312815440},"quantilePoints":[{"date":"2021-07-02","current":-3.93088,"twenty":-3.777987,"median":-3.548648,"eighty":-1.800418,"marketCap":312957000},{"date":"2021-07-09","current":-3.99351,"twenty":-3.930489,"median":-3.899589,"eighty":-3.618836,"marketCap":317943300},{"date":"2021-07-16","current":-3.973643,"twenty":-4.000143,"median":-3.952262,"eighty":-3.899589,"marketCap":316361556},{"date":"2021-07-23","current":-3.981493,"twenty":-3.996715,"median":-3.969477,"eighty":-3.905456,"marketCap":316986600},{"date":"2021-07-30","current":-3.945444,"twenty":-3.991107,"median":-3.951452,"eighty":-3.929315,"marketCap":314116500},{"date":"2021-08-06","current":-3.941438,"twenty":-3.979923,"median":-3.953455,"eighty":-3.932992,"marketCap":313797600},{"date":"2021-08-13","current":-3.93543,"twenty":-3.973611,"median":-3.945444,"eighty":-3.931389,"marketCap":313319250},{"date":"2021-08-20","current":-3.913399,"twenty":-3.972681,"median":-3.945444,"eighty":-3.930066,"marketCap":311565300},{"date":"2021-08-27","current":-3.893372,"twenty":-3.968676,"median":-3.943441,"eighty":-3.922212,"marketCap":309970800},{"date":"2021-09-03","current":-3.905388,"twenty":-3.96467,"median":-3.941438,"eighty":-3.90699,"marketCap":310927500},{"date":"2021-09-10","current":-3.921411,"twenty":-3.961466,"median":-3.93543,"eighty":-3.905388,"marketCap":312203100},{"date":"2021-09-17","current":-3.925416,"twenty":-3.959463,"median":-3.933427,"eighty":-3.905388,"marketCap":312522000},{"date":"2021-09-24","current":-3.917405,"twenty":-3.95746,"median":-3.933427,"eighty":-3.913399,"marketCap":311884200},{"date":"2021-10-01","current":-3.953455,"twenty":-3.953455,"median":-3.932154,"eighty":-3.913399,"marketCap":314754300},{"date":"2021-10-08","current":-3.933427,"twenty":-3.953455,"median":-3.933427,"eighty":-3.913399,"marketCap":313159800},{"date":"2021-10-15","current":-3.953455,"twenty":-3.953455,"median":-3.933427,"eighty":-3.917405,"marketCap":314754300},{"date":"2021-10-22","current":-3.953455,"twenty":-3.953455,"median":-3.933427,"eighty":-3.917405,"marketCap":314754300},{"date":"2021-10-29","current":-3.973482,"twenty":-3.953455,"median":-3.937092,"eighty":-3.921411,"marketCap":316348800},{"date":"2021-11-05","current":-3.985499,"twenty":-3.965471,"median":-3.941438,"eighty":-3.921411,"marketCap":317305500},{"date":"2021-11-12","current":-3.969477,"twenty":-3.969477,"median":-3.941438,"eighty":-3.921411,"marketCap":316029900},{"date":"2021-11-19","current":-3.973402,"twenty":-3.969477,"median":-3.945444,"eighty":-3.921411,"marketCap":316342422},{"date":"2021-11-26","current":-3.965471,"twenty":-3.970262,"median":-3.945444,"eighty":-3.924615,"marketCap":315711000},{"date":"2021-12-03","current":-3.965471,"twenty":-3.970262,"median":-3.945444,"eighty":-3.925416,"marketCap":315711000},{"date":"2021-12-10","current":-3.95746,"twenty":-3.969477,"median":-3.945444,"eighty":-3.925416,"marketCap":315073200},{"date":"2021-12-17","current":-3.933868,"twenty":-3.969477,"median":-3.945444,"eighty":-3.925416,"marketCap":313194879},{"date":"2021-12-23","current":-3.949449,"twenty":-3.968275,"median":-3.945444,"eighty":-3.925416,"marketCap":314435400},{"date":"2021-12-31","current":-3.965471,"twenty":-3.966272,"median":-3.946645,"eighty":-3.925416,"marketCap":315711000},{"date":"2022-01-07","current":-3.961466,"twenty":-3.966272,"median":-3.949449,"eighty":-3.925416,"marketCap":315392100},{"date":"2022-01-14","current":-3.941038,"twenty":-3.965471,"median":-3.949449,"eighty":-3.925416,"marketCap":313765710},{"date":"2022-01-21","current":-3.937433,"twenty":-3.965471,"median":-3.946645,"eighty":-3.926819,"marketCap":313478700},{"date":"2022-01-28","current":-3.937433,"twenty":-3.965471,"median":-3.945444,"eighty":-3.925416,"marketCap":313478700},{"date":"2022-02-04","current":-3.949449,"twenty":-3.965471,"median":-3.945444,"eighty":-3.926819,"marketCap":314435400},{"date":"2022-02-11","current":-3.937433,"twenty":-3.965471,"median":-3.945444,"eighty":-3.929123,"marketCap":313478700},{"date":"2022-02-18","current":-6.405415,"twenty":-3.965471,"median":-3.945444,"eighty":-3.929598,"marketCap":314435400},{"date":"2022-02-25","current":-6.418407,"twenty":-3.969477,"median":-3.946645,"eighty":-3.930066,"marketCap":315073200},{"date":"2022-03-04","current":-6.415159,"twenty":-3.973466,"median":-3.949449,"eighty":-3.931389,"marketCap":314913750},{"date":"2022-03-11","current":-6.405415,"twenty":-3.973482,"median":-3.949449,"eighty":-3.933427,"marketCap":314435400},{"date":"2022-03-18","current":-6.4314,"twenty":-3.977488,"median":-3.949449,"eighty":-3.933427,"marketCap":315711000},{"date":"2022-03-25","current":-6.4314,"twenty":-3.988703,"median":-3.949449,"eighty":-3.933427,"marketCap":315711000},{"date":"2022-04-01","current":-6.426723,"twenty":-3.99351,"median":-3.953455,"eighty":-3.933427,"marketCap":315481392},{"date":"2022-04-08","current":-6.418407,"twenty":-4.009532,"median":-3.953455,"eighty":-3.933427,"marketCap":315073200},{"date":"2022-04-14","current":-5.713437,"twenty":-5.713437,"median":-3.953455,"eighty":-3.933427,"marketCap":315073200},{"date":"2022-04-22","current":-5.71922,"twenty":-5.71922,"median":-3.953455,"eighty":-3.933427,"marketCap":315392100},{"date":"2022-04-29","current":-5.713437,"twenty":-5.71922,"median":-3.953455,"eighty":-3.933427,"marketCap":315073200},{"date":"2022-05-06","current":-5.701871,"twenty":-5.71922,"median":-3.953455,"eighty":-3.933427,"marketCap":314435400},{"date":"2022-05-13","current":-5.690306,"twenty":-5.71922,"median":-3.95746,"eighty":-3.933427,"marketCap":313797600},{"date":"2022-05-20","current":-5.684523,"twenty":-5.71922,"median":-3.961426,"eighty":-3.933868,"marketCap":313478700},{"date":"2022-05-27","current":-5.696089,"twenty":-5.716907,"median":-3.961466,"eighty":-3.93543,"marketCap":314116500},{"date":"2022-06-03","current":-5.701871,"twenty":-5.71737,"median":-3.961866,"eighty":-3.936488,"marketCap":314435400},{"date":"2022-06-10","current":-2.837909,"twenty":-5.714131,"median":-3.965471,"eighty":-3.936488,"marketCap":315073200},{"date":"2022-06-17","current":-2.852271,"twenty":-5.713437,"median":-3.961466,"eighty":-3.933427,"marketCap":316667700},{"date":"2022-06-24","current":-2.863761,"twenty":-5.713437,"median":-3.961466,"eighty":-3.933427,"marketCap":317943300},{"date":"2022-07-01","current":-2.820675,"twenty":-5.713437,"median":-3.960425,"eighty":-3.933427,"marketCap":313159800},{"date":"2022-07-08","current":-2.872378,"twenty":-5.713437,"median":-3.95746,"eighty":-3.929598,"marketCap":318900000},{"date":"2022-07-15","current":-15.272623,"twenty":-5.715519,"median":-3.961386,"eighty":-3.930269,"marketCap":1695612421},{"date":"2022-07-22","current":-18.82833,"twenty":-5.71922,"median":-3.961466,"eighty":-3.931899,"marketCap":2090377728},{"date":"2022-07-29","current":-20.585641,"twenty":-5.733098,"median":-3.961866,"eighty":-3.933427,"marketCap":2285479649},{"date":"2022-08-05","current":-15.481072,"twenty":-6.400867,"median":-3.965471,"eighty":-3.933427,"marketCap":1718755020},{"date":"2022-08-12","current":-15.351975,"twenty":-6.405415,"median":-3.965471,"eighty":-3.933427,"marketCap":1848822968},{"date":"2022-08-19","current":-12.729024,"twenty":-6.405415,"median":-3.965471,"eighty":-3.933427,"marketCap":1532943667},{"date":"2022-08-26","current":-14.4648,"twenty":-6.405415,"median":-3.965471,"eighty":-3.933427,"marketCap":1741981440},{"date":"2022-09-02","current":-19.672128,"twenty":-6.411911,"median":-3.965471,"eighty":-3.933427,"marketCap":2369094758},{"date":"2022-09-09","current":-18.977818,"twenty":-6.418407,"median":-3.968476,"eighty":-3.933427,"marketCap":2285479649},{"date":"2022-09-16","current":-19.55641,"twenty":-6.418407,"median":-3.969477,"eighty":-3.933427,"marketCap":2355158906},{"date":"2022-09-23","current":-17.743488,"twenty":-6.430465,"median":-3.973442,"eighty":-3.933427,"marketCap":2136830566},{"date":"2022-09-30","current":-17.377047,"twenty":-6.4314,"median":-3.973482,"eighty":-3.933515,"marketCap":2092700369},{"date":"2022-10-07","current":-18.244935,"twenty":-6.443094,"median":-3.973482,"eighty":-3.93418,"marketCap":2197219256},{"date":"2022-10-14","current":-19.112823,"twenty":-13.50048,"median":-3.977488,"eighty":-3.935694,"marketCap":2301738142},{"date":"2022-10-21","current":-19.807133,"twenty":-14.4648,"median":-3.981493,"eighty":-3.936888,"marketCap":2385353251},{"date":"2022-10-28","current":-20.25072,"twenty":-14.946961,"median":-3.989504,"eighty":-3.937433,"marketCap":2438774016},{"date":"2022-11-04","current":-20.173575,"twenty":-15.336105,"median":-3.99351,"eighty":-3.937433,"marketCap":2429483448},{"date":"2022-11-11","current":-21.947924,"twenty":-15.735278,"median":-3.997516,"eighty":-3.937433,"marketCap":2643166504},{"date":"2022-11-18","current":-19.595346,"twenty":-16.653537,"median":-4.009532,"eighty":-3.937433,"marketCap":2257677822},{"date":"2022-11-25","current":-18.807492,"twenty":-17.068464,"median":-5.684523,"eighty":-3.937433,"marketCap":2166905209},{"date":"2022-12-02","current":-20.827631,"twenty":-17.18714,"median":-5.684523,"eighty":-3.937433,"marketCap":2399655500},{"date":"2022-12-09","current":-21.11045,"twenty":-17.743488,"median":-5.690306,"eighty":-3.937473,"marketCap":2432240540},{"date":"2022-12-16","current":-16.16111,"twenty":-17.936352,"median":-5.696089,"eighty":-3.937473,"marketCap":1862002328},{"date":"2022-12-23","current":-13.191506,"twenty":-17.743488,"median":-5.700425,"eighty":-3.941038,"marketCap":1519859400},{"date":"2022-12-30","current":-13.858152,"twenty":-17.592702,"median":-5.701871,"eighty":-3.941358,"marketCap":1596666996},{"date":"2023-01-06","current":-12.322847,"twenty":-17.552377,"median":-5.701871,"eighty":-3.941438,"marketCap":1419776775},{"date":"2023-01-13","current":-17.02977,"twenty":-17.446478,"median":-5.701871,"eighty":-3.941438,"marketCap":1962084953},{"date":"2023-01-20","current":-19.130714,"twenty":-17.859206,"median":-5.702392,"eighty":-3.941438,"marketCap":2204145255},{"date":"2023-01-27","current":-20.443805,"twenty":-18.233773,"median":-5.707654,"eighty":-3.941438,"marketCap":2355432944},{"date":"2023-02-03","current":-20.989242,"twenty":-18.403464,"median":-5.707712,"eighty":-3.941438,"marketCap":2418275523},{"date":"2023-02-10","current":-24.16086,"twenty":-18.54966,"median":-5.711991,"eighty":-3.941438,"marketCap":2783693480},{"date":"2023-02-17","current":-23.413409,"twenty":-18.757953,"median":-5.713437,"eighty":-3.941438,"marketCap":2697575872},{"date":"2023-02-24","current":-23.231596,"twenty":-18.803452,"median":-5.713437,"eighty":-3.941438,"marketCap":2676628346},{"date":"2023-03-03","current":-23.2922,"twenty":-18.917062,"median":-5.718063,"eighty":-3.941438,"marketCap":2683610855},{"date":"2023-03-10","current":-24.181061,"twenty":-19.028532,"median":-5.71922,"eighty":-3.941438,"marketCap":2786020983},{"date":"2023-03-17","current":-25.150728,"twenty":-19.208976,"median":-5.722112,"eighty":-3.942239,"marketCap":2897741122},{"date":"2023-03-24","current":-25.494152,"twenty":-19.330057,"median":-5.736568,"eighty":-3.945444,"marketCap":2937308672},{"date":"2023-03-31","current":-24.616008,"twenty":-19.483122,"median":-6.398918,"eighty":-3.945444,"marketCap":2659316609},{"date":"2023-04-06","current":-19.853724,"twenty":-19.575696,"median":-6.40379,"eighty":-3.945444,"marketCap":2144837513},{"date":"2023-04-14","current":-25.98598,"twenty":-19.672128,"median":-6.405415,"eighty":-3.945444,"marketCap":2807317445},{"date":"2023-04-21","current":-25.333613,"twenty":-19.853724,"median":-6.405415,"eighty":-3.945444,"marketCap":2736840857},{"date":"2023-04-28","current":-21.288933,"twenty":-20.019575,"median":-6.405415,"eighty":-3.945444,"marketCap":2299886007},{"date":"2023-05-05","current":-20.114671,"twenty":-20.18945,"median":-6.405415,"eighty":-3.945444,"marketCap":2173028148},{"date":"2023-05-12","current":-19.614523,"twenty":-20.18945,"median":-6.405415,"eighty":-3.945444,"marketCap":2118996097},{"date":"2023-05-19","current":-44.065072,"twenty":-20.25072,"median":-6.411911,"eighty":-3.945444,"marketCap":2212551337},{"date":"2023-05-26","current":-47.998617,"twenty":-20.284306,"median":-6.416783,"eighty":-3.945444,"marketCap":2410058576},{"date":"2023-06-02","current":-52.494098,"twenty":-20.388666,"median":-6.418407,"eighty":-3.945444,"marketCap":2635781135},{"date":"2023-06-09","current":-53.758451,"twenty":-20.558266,"median":-6.418407,"eighty":-3.945444,"marketCap":2699265605},{"date":"2023-06-16","current":-52.681409,"twenty":-20.807959,"median":-6.421655,"eighty":-3.945444,"marketCap":2645186242},{"date":"2023-06-23","current":-51.978991,"twenty":-20.95692,"median":-6.429061,"eighty":-3.945444,"marketCap":2609917092},{"date":"2023-06-30","current":-49.450283,"twenty":-21.10237,"median":-6.4314,"eighty":-3.945444,"marketCap":2482948152},{"date":"2023-07-07","current":-51.885335,"twenty":-21.171055,"median":-6.4314,"eighty":-3.945444,"marketCap":2605214539},{"date":"2023-07-14","current":-52.587753,"twenty":-21.332666,"median":-6.437896,"eighty":-3.946645,"marketCap":2640483689},{"date":"2023-07-21","current":-52.21313,"twenty":-21.898305,"median":-8.747276,"eighty":-3.949449,"marketCap":2621673475},{"date":"2023-07-28","current":-53.196516,"twenty":-22.221527,"median":-12.423854,"eighty":-3.949449,"marketCap":2671050285},{"date":"2023-08-04","current":-57.083234,"twenty":-22.625554,"median":-12.748151,"eighty":-3.949449,"marketCap":2866206248},{"date":"2023-08-11","current":-80.445898,"twenty":-22.928575,"median":-13.50048,"eighty":-3.949449,"marketCap":2992426529},{"date":"2023-08-18","current":-61.789027,"twenty":-23.231596,"median":-13.823964,"eighty":-3.949449,"marketCap":2298428238},{"date":"2023-08-25","current":-56.350075,"twenty":-23.398255,"median":-13.959159,"eighty":-3.949449,"marketCap":2096110092},{"date":"2023-09-01","current":-54.263035,"twenty":-23.736631,"median":-14.199098,"eighty":-3.949449,"marketCap":2018476385},{"date":"2023-09-08","current":-50.405174,"twenty":-24.063893,"median":-14.4648,"eighty":-3.949449,"marketCap":1874971654},{"date":"2023-09-15","current":-44.017567,"twenty":-24.159653,"median":-14.727938,"eighty":-3.949449,"marketCap":1637365459},{"date":"2023-09-22","current":-27.510979,"twenty":-24.249746,"median":-14.918031,"eighty":-3.949449,"marketCap":1023353412},{"date":"2023-09-29","current":-29.78775,"twenty":-24.642103,"median":-15.00482,"eighty":-3.951051,"marketCap":1108044729},{"date":"2023-10-06","current":-30.040725,"twenty":-25.154768,"median":-15.242134,"eighty":-3.953054,"marketCap":1117454875},{"date":"2023-10-13","current":-16.127126,"twenty":-25.364057,"median":-15.454062,"eighty":-3.953455,"marketCap":599896827},{"date":"2023-10-20","current":-13.945221,"twenty":-25.203466,"median":-15.467567,"eighty":-3.953455,"marketCap":518734315},{"date":"2023-10-27","current":-11.605206,"twenty":-25.166889,"median":-15.403018,"eighty":-3.953455,"marketCap":431690462},{"date":"2023-11-03","current":-11.510341,"twenty":-25.100323,"median":-15.211645,"eighty":-3.953455,"marketCap":428161657},{"date":"2023-11-10","current":-10.561686,"twenty":-24.885654,"median":-14.997125,"eighty":-3.953455,"marketCap":392873608},{"date":"2023-11-17","current":-7.987659,"twenty":-24.816068,"median":-14.869815,"eighty":-3.953455,"marketCap":289584594},{"date":"2023-11-24","current":-11.494688,"twenty":-24.746482,"median":-14.727938,"eighty":-3.953455,"marketCap":416728417},{"date":"2023-12-01","current":-3.111096,"twenty":-24.616008,"median":-14.4648,"eighty":-3.953455,"marketCap":112789679},{"date":"2023-12-08","current":-3.351836,"twenty":-24.616008,"median":-14.156218,"eighty":-3.949449,"marketCap":121517452},{"date":"2023-12-15","current":-3.555538,"twenty":-24.484082,"median":-13.999623,"eighty":-3.949449,"marketCap":128902490},{"date":"2023-12-22","current":-3.592575,"twenty":-24.443679,"median":-13.878354,"eighty":-3.949449,"marketCap":130245225},{"date":"2023-12-29","current":-3.370354,"twenty":-24.395196,"median":-13.868253,"eighty":-3.949449,"marketCap":122188819},{"date":"2024-01-05","current":-2.796283,"twenty":-24.249746,"median":-13.789776,"eighty":-3.945444,"marketCap":101376438},{"date":"2024-01-12","current":-2.925912,"twenty":-24.185101,"median":-13.345993,"eighty":-3.945444,"marketCap":106076008},{"date":"2024-01-19","current":-2.499988,"twenty":-24.181061,"median":-12.748151,"eighty":-3.945444,"marketCap":90634563},{"date":"2024-01-26","current":-2.925912,"twenty":-24.16894,"median":-12.423854,"eighty":-3.945444,"marketCap":106076008},{"date":"2024-02-02","current":-2.388877,"twenty":-24.159955,"median":-11.842053,"eighty":-3.941438,"marketCap":86606361},{"date":"2024-02-09","current":-2.333322,"twenty":-24.148136,"median":-11.494688,"eighty":-3.941438,"marketCap":84592259},{"date":"2024-02-16","current":-2.370359,"twenty":-24.138827,"median":-11.122141,"eighty":-3.941438,"marketCap":85934993},{"date":"2024-02-23","current":-2.777764,"twenty":-24.114585,"median":-10.640741,"eighty":-3.938899,"marketCap":100705071},{"date":"2024-03-01","current":-3.018504,"twenty":-24.071974,"median":-10.530065,"eighty":-3.937433,"marketCap":109432843},{"date":"2024-03-08","current":-3.074059,"twenty":-23.995209,"median":-10.245469,"eighty":-3.937024,"marketCap":111446945},{"date":"2024-03-15","current":-2.518506,"twenty":-23.890162,"median":-10.118981,"eighty":-3.933427,"marketCap":91305931},{"date":"2024-03-22","current":-2.537025,"twenty":-23.821477,"median":-9.694547,"eighty":-3.933427,"marketCap":91977298},{"date":"2024-03-28","current":-2.727684,"twenty":-23.712389,"median":-8.507181,"eighty":-3.933427,"marketCap":96745488},{"date":"2024-04-05","current":-2.501825,"twenty":-23.59942,"median":-6.444393,"eighty":-3.92951,"marketCap":88734715},{"date":"2024-04-12","current":-2.8493,"twenty":-23.533657,"median":-6.434713,"eighty":-3.925416,"marketCap":101058981},{"date":"2024-04-19","current":-4.169708,"twenty":-23.503987,"median":-6.4314,"eighty":-3.925416,"marketCap":147891192},{"date":"2024-04-26","current":-4.708295,"twenty":-23.410378,"median":-6.4314,"eighty":-3.925416,"marketCap":166993804},{"date":"2024-05-03","current":-3.8749,"twenty":-23.393205,"median":-6.424904,"eighty":-3.925416,"marketCap":137434944},{"date":"2024-05-10","current":-4.703948,"twenty":-23.370986,"median":-6.418407,"eighty":-3.925416,"marketCap":166839630},{"date":"2024-05-17","current":-6.864118,"twenty":-23.348764,"median":-6.418407,"eighty":-3.925416,"marketCap":242269041},{"date":"2024-05-24","current":-6.357006,"twenty":-23.280079,"median":-6.421655,"eighty":-3.925416,"marketCap":224370537},{"date":"2024-05-31","current":-7.606674,"twenty":-23.231596,"median":-6.425814,"eighty":-3.925416,"marketCap":268477566},{"date":"2024-06-07","current":-6.520006,"twenty":-23.231596,"median":-6.424904,"eighty":-3.925416,"marketCap":230123628},{"date":"2024-06-14","current":-9.906566,"twenty":-23.231596,"median":-6.424904,"eighty":-3.925416,"marketCap":349652231},{"date":"2024-06-21","current":-8.670299,"twenty":-23.219475,"median":-6.4314,"eighty":-3.927521,"marketCap":306018191},{"date":"2024-06-28","current":-8.196142,"twenty":-23.211395,"median":-6.4314,"eighty":-3.928924,"marketCap":289282821},{"date":"2024-07-05","current":-7.891327,"twenty":-22.985139,"median":-6.4314,"eighty":-3.929322,"marketCap":278524369},{"date":"2024-07-12","current":-8.128405,"twenty":-22.904201,"median":-6.431465,"eighty":-3.929774,"marketCap":286892054},{"date":"2024-07-15","current":-7.959063,"twenty":-22.898107,"median":-6.43153,"eighty":-3.929862,"marketCap":280915136},{"date":"2024-08-02","current":-7.383301,"twenty":-22.870757,"median":-6.434713,"eighty":-3.930066,"marketCap":260593616},{"date":"2024-08-09","current":-7.078486,"twenty":-22.753916,"median":-6.43153,"eighty":-3.931389,"marketCap":249835164},{"date":"2024-08-16","current":-7.78799,"twenty":-22.704424,"median":-6.441145,"eighty":-3.933427,"marketCap":301262805},{"date":"2024-08-23","current":-7.103689,"twenty":-22.566987,"median":-6.556229,"eighty":-3.933427,"marketCap":274792014},{"date":"2024-08-30","current":-7.755404,"twenty":-22.313847,"median":-6.710173,"eighty":-3.933427,"marketCap":300002291},{"date":"2024-09-06","current":-7.722818,"twenty":-22.23835,"median":-6.820975,"eighty":-3.933427,"marketCap":298741777},{"date":"2024-09-13","current":-7.755404,"twenty":-22.221527,"median":-7.027118,"eighty":-3.933427,"marketCap":300002291},{"date":"2024-09-20","current":-7.78799,"twenty":-22.221527,"median":-7.101626,"eighty":-3.933427,"marketCap":301262805},{"date":"2024-09-27","current":-6.647489,"twenty":-22.137011,"median":-7.103689,"eighty":-3.933427,"marketCap":257144821},{"date":"2024-10-04","current":-5.067081,"twenty":-22.12052,"median":-7.052802,"eighty":-3.933427,"marketCap":196009900},{"date":"2024-10-11","current":-5.539574,"twenty":-21.947924,"median":-6.864118,"eighty":-3.933427,"marketCap":214287351},{"date":"2024-10-18","current":-6.451975,"twenty":-21.898305,"median":-6.715945,"eighty":-3.933427,"marketCap":249581738},{"date":"2024-10-25","current":-5.621039,"twenty":-21.615485,"median":-6.664895,"eighty":-3.933868,"marketCap":217438635},{"date":"2024-10-31","current":-5.474403,"twenty":-21.486196,"median":-6.556229,"eighty":-3.935118,"marketCap":211766323},{"date":"2024-11-08","current":-6.289046,"twenty":-21.4263,"median":-6.448184,"eighty":-3.936488,"marketCap":243279169},{"date":"2024-11-15","current":-6.0324,"twenty":-21.350014,"median":-6.444393,"eighty":-3.937297,"marketCap":275131722},{"date":"2024-11-22","current":-4.882035,"twenty":-21.29768,"median":-6.434713,"eighty":-3.937433,"marketCap":222664742},{"date":"2024-11-29","current":-5.611535,"twenty":-21.230327,"median":-6.4314,"eighty":-3.937433,"marketCap":255936486},{"date":"2024-12-06","current":-5.359016,"twenty":-21.179135,"median":-6.4314,"eighty":-3.937433,"marketCap":244419344},{"date":"2024-12-13","current":-5.274843,"twenty":-21.171055,"median":-6.425814,"eighty":-3.937433,"marketCap":240580296},{"date":"2024-12-20","current":-4.09642,"twenty":-21.146813,"median":-6.418407,"eighty":-3.937433,"marketCap":186833634},{"date":"2024-12-27","current":-5.050381,"twenty":-21.122571,"median":-6.418407,"eighty":-3.937449,"marketCap":230342837},{"date":"2025-01-03","current":-4.853978,"twenty":-21.11045,"median":-6.418407,"eighty":-3.937473,"marketCap":221385060},{"date":"2025-01-10","current":-4.657574,"twenty":-21.11045,"median":-6.418407,"eighty":-3.937473,"marketCap":212427283},{"date":"2025-01-17","current":-4.629516,"twenty":-21.070048,"median":-6.411911,"eighty":-3.941038,"marketCap":211147600},{"date":"2025-01-24","current":-4.769804,"twenty":-21.021564,"median":-6.405513,"eighty":-3.941358,"marketCap":217546013},{"date":"2025-01-31","current":-4.685631,"twenty":-20.993282,"median":-6.405415,"eighty":-3.941438,"marketCap":213706965},{"date":"2025-02-07","current":-4.657574,"twenty":-20.924597,"median":-6.405415,"eighty":-3.941438,"marketCap":212427283},{"date":"2025-02-14","current":-4.489228,"twenty":-20.892275,"median":-6.405415,"eighty":-3.941438,"marketCap":204749188},{"date":"2025-02-21","current":-4.264766,"twenty":-20.851873,"median":-6.405415,"eighty":-3.941438,"marketCap":194511729},{"date":"2025-02-28","current":-3.521238,"twenty":-20.807959,"median":-6.405415,"eighty":-3.941438,"marketCap":160600144},{"date":"2025-03-07","current":-2.917998,"twenty":-20.791208,"median":-6.398918,"eighty":-3.939612,"marketCap":133086972},{"date":"2025-03-14","current":-2.673055,"twenty":-20.739367,"median":-6.377962,"eighty":-3.937433,"marketCap":121915345},{"date":"2025-03-21","current":-1.995143,"twenty":-20.633954,"median":-6.302673,"eighty":-3.937161,"marketCap":122074840},{"date":"2025-03-28","current":-1.99599,"twenty":-20.558266,"median":-6.244118,"eighty":-3.933427,"marketCap":122126654},{"date":"2025-04-04","current":-1.506096,"twenty":-20.532709,"median":-6.10345,"eighty":-3.933427,"marketCap":92151996},{"date":"2025-04-11","current":-1.298833,"twenty":-20.477418,"median":-6.077239,"eighty":-3.933427,"marketCap":79470410},{"date":"2025-04-17","current":-1.68499,"twenty":-20.442625,"median":-6.03038,"eighty":-3.929598,"marketCap":103097798},{"date":"2025-04-25","current":-2.09634,"twenty":-20.406062,"median":-5.963189,"eighty":-3.925416,"marketCap":128266667},{"date":"2025-05-02","current":-1.807993,"twenty":-20.351185,"median":-5.823259,"eighty":-3.925416,"marketCap":110623847},{"date":"2025-05-09","current":-1.481961,"twenty":-20.325394,"median":-5.807938,"eighty":-3.921411,"marketCap":90675284},{"date":"2025-05-16","current":-1.608506,"twenty":-20.288531,"median":-5.750745,"eighty":-3.917405,"marketCap":110066842},{"date":"2025-05-23","current":-1.394972,"twenty":-20.269604,"median":-5.727894,"eighty":-3.910996,"marketCap":95455167},{"date":"2025-05-30","current":-1.363927,"twenty":-20.25072,"median":-5.723765,"eighty":-3.905388,"marketCap":93330775},{"date":"2025-06-06","current":-1.489813,"twenty":-20.25072,"median":-5.71922,"eighty":-3.899589,"marketCap":101944927},{"date":"2025-06-13","current":-1.696153,"twenty":-20.25072,"median":-5.71922,"eighty":-3.890077,"marketCap":116064364},{"date":"2025-06-20","current":-1.318115,"twenty":-20.25072,"median":-5.713437,"eighty":-3.721706,"marketCap":90196001},{"date":"2025-06-27","current":-1.36847,"twenty":-20.212148,"median":-5.713437,"eighty":-3.555538,"marketCap":93641661},{"date":"2025-07-03","current":-1.206237,"twenty":-20.196718,"median":-5.713437,"eighty":-3.50958,"marketCap":82540416},{"date":"2025-07-11","current":-10.099816,"twenty":-20.190132,"median":-5.713437,"eighty":-3.460576,"marketCap":691110197},{"date":"2025-07-18","current":-6.863195,"twenty":-20.17675,"median":-5.713437,"eighty":-3.50958,"marketCap":469634728},{"date":"2025-07-25","current":-6.356023,"twenty":-20.126452,"median":-5.716907,"eighty":-3.539649,"marketCap":434929943},{"date":"2025-08-01","current":-5.40067,"twenty":-20.087078,"median":-5.715172,"eighty":-3.547769,"marketCap":369557037},{"date":"2025-08-08","current":-5.000981,"twenty":-20.031696,"median":-5.713437,"eighty":-3.55416,"marketCap":342207148},{"date":"2025-08-15","current":-4.45503,"twenty":-19.942197,"median":-5.713437,"eighty":-3.585168,"marketCap":322873875},{"date":"2025-08-22","current":-4.321343,"twenty":-19.919425,"median":-5.713437,"eighty":-3.623411,"marketCap":313184989},{"date":"2025-08-29","current":-4.656619,"twenty":-19.906566,"median":-5.709129,"eighty":-3.644222,"marketCap":337483825},{"date":"2025-09-05","current":-4.28409,"twenty":-19.87366,"median":-5.707654,"eighty":-3.692023,"marketCap":310485119},{"date":"2025-09-12","current":-5.55069,"twenty":-19.825769,"median":-5.702508,"eighty":-3.781181,"marketCap":402280719},{"date":"2025-09-19","current":-5.047775,"twenty":-19.795945,"median":-5.702447,"eighty":-3.853272,"marketCap":365832466},{"date":"2025-09-26","current":-4.880137,"twenty":-19.776531,"median":-5.701871,"eighty":-3.88358,"marketCap":353683048},{"date":"2025-10-03","current":-5.178161,"twenty":-19.737357,"median":-5.701871,"eighty":-3.8915,"marketCap":375282013},{"date":"2025-10-10","current":-6.146737,"twenty":-19.694477,"median":-5.701871,"eighty":-3.893192,"marketCap":445478649},{"date":"2025-10-17","current":-5.662449,"twenty":-19.67518,"median":-5.701871,"eighty":-3.893372,"marketCap":410380331},{"date":"2025-10-24","current":-5.941846,"twenty":-19.672128,"median":-5.701871,"eighty":-3.897102,"marketCap":430629360},{"date":"2025-10-31","current":-5.778791,"twenty":-19.672128,"median":-5.701871,"eighty":-3.899589,"marketCap":418812070},{"date":"2025-11-07","current":-5.272208,"twenty":-19.637565,"median":-5.701871,"eighty":-3.900665,"marketCap":382098025},{"date":"2025-11-14","current":-4.364587,"twenty":-19.603017,"median":-5.701871,"eighty":-3.901383,"marketCap":310029714},{"date":"2025-11-21","current":-4.164684,"twenty":-19.583556,"median":-5.69898,"eighty":-3.903786,"marketCap":295829986},{"date":"2025-11-28","current":-4.423731,"twenty":-19.57383,"median":-5.696089,"eighty":-3.905388,"marketCap":314230894},{"date":"2025-12-05","current":-5.121166,"twenty":-19.565183,"median":-5.690306,"eighty":-3.905388,"marketCap":363771801},{"date":"2025-12-12","current":-4.423731,"twenty":-19.540981,"median":-5.684523,"eighty":-3.90699,"marketCap":314230894},{"date":"2025-12-15","current":-4.403804,"twenty":-19.533266,"median":-5.684523,"eighty":-3.907792,"marketCap":312815440}],"updateTime":1765880772303},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PROK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583681026","title":"ProKidney Corp. Director Brian JG Pereira Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583681026","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583681026?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:09","pubTimestamp":1763154590,"startTime":"0","endTime":"0","summary":"Brian JG Pereira, Director of ProKidney Corp., has reported a disposal of common shares of ProKidney Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL1Wrsx1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ProKidney Corp. Director Brian JG Pereira Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2582383803","title":"ProKidney Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $217.000K Beat $44.250K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582383803","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582383803?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:36","pubTimestamp":1762810564,"startTime":"0","endTime":"0","summary":"ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 13.04 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48767698/prokidney-q3-eps-0-12-beats-0-14-estimate-sales-217-000k-beat-44-250k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ProKidney Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $217.000K Beat $44.250K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSYW.SI","TQQQ",".IXIC","PSQ","QID","USJW.SI","BK4139","USAW.SI","QLD","SQQQ","NVIW.SI","MNQmain","PROK","NQmain"],"gpt_icon":0},{"id":"2582030800","title":"ProKidney reports Q3 2025 results and updates on Phase 3 CKD therapy trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2582030800","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582030800?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:16","pubTimestamp":1762809379,"startTime":"0","endTime":"0","summary":"ProKidney Corp. reported cash, cash equivalents, and marketable securities totaling $271.7 million as of September 30, 2025, compared to $358.3 million at the end of 2024. The company expects these funds to support operations into mid-2027. More than half of the patients required for the Phase 3 PROACT 1 study for rilparencel have been enrolled, with topline results expected in the second quarter of 2027. The FDA confirmed that estimated glomerular filtration rate  slope can serve as the primary endpoint for a Biologics License Application submission for rilparencel under the accelerated approval pathway. Full Phase 2 results for rilparencel were recently presented, showing statistically significant stabilization of kidney function.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interprete","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL1NBkHm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2582385110","title":"ProKidney: Q3 Net Loss per Share Attributable to Class a Stock $0.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2582385110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582385110?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:15","pubTimestamp":1762809302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nPLXAFC7F2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2582800043","title":"Press Release: ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800043","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800043?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:15","pubTimestamp":1762809300,"startTime":"0","endTime":"0","summary":"-- Full results from the Phase 2 REGEN-007 study of rilparencel were. recently presented as a late-breaking clinical trial at the American. -- More than half of the patients required for the Phase 3 REGEN-006 (PROACT. 1) accelerated approval analysis using estimated glomerular filtration. rate  slope have been enrolled; topline results anticipated in Q2. -- Ended the third quarter with $272 million in cash and cash equivalents. Phase 2 REGEN-007 Full Results Recently Presented at ASN Kidney Week 2025. On November 6, 2025, ProKidney presented full results from the Phase 2 REGEN-007 study evaluating rilparencel in patients with advanced CKD and diabetes. The data, featured in a late-breaking clinical trials presentation, further demonstrate the potential of rilparencel to preserve kidney function in patients with advanced CKD and diabetes who are at high risk of kidney failure. Highlights include:. in a 4.6 mL/min/1.73m2 improvement in the annual decline in eGFR slope;this 78% improvemen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4213","SOC","BK4139"],"gpt_icon":0},{"id":"2581002847","title":"Prokidney Corp  expected to post a loss of 13 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581002847","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581002847?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:53","pubTimestamp":1762516387,"startTime":"0","endTime":"0","summary":"Prokidney Corp  expected to post a loss of13cents a share - Earnings Preview Prokidney Corp PROK.OQ PROK.O is expected to  show no change in quarterly revenue when it reports  results on November 10 (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ1BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2581090619","title":"ProKidney Announces Phase 3 Trial Progress for Rilparencel in Advanced CKD and Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2581090619","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581090619?lang=en_us&edition=fundamental","pubTime":"2025-11-07 00:00","pubTimestamp":1762444818,"startTime":"0","endTime":"0","summary":"ProKidney Corp. has announced updated results from the Phase 2 REGEN-007 trial and provided an update on the ongoing Phase 3 PROACT 1 registrational program for rilparencel, its investigational autologous cell therapy for patients with advanced chronic kidney disease  and type 2 diabetes. Full results from the Phase 2 trial were presented at the American Society of Nephrology Kidney Week 2025. In the study, bilateral kidney injection with rilparencel demonstrated a statistically significant and clinically meaningful slowing of CKD progression, with a 4.6 mL/min/1.73m (78%) improvement in the annual decline of estimated glomerular filtration rate  slope in one patient group. No rilparencel-related serious adverse events were observed. The Phase 3 PROACT 1 trial is ongoing, with more than half of the approximately 360 patients required for the accelerated approval analysis already enrolled as of August 2025. The U.S. Food and Drug Administration  has confirmed that eGFR slope is an accep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL317Sf7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","PROK","BK4139","NDAQ","IE00BKPKM429.USD","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD"],"gpt_icon":0},{"id":"2581905290","title":"ProKidney Presents Full Results From the Phase 2 Regen-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581905290","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581905290?lang=en_us&edition=fundamental","pubTime":"2025-11-07 00:00","pubTimestamp":1762444800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA5FSZL7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2579977409","title":"ProKidney Corp. to Join Guggenheim Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2579977409","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579977409?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:30","pubTimestamp":1761737416,"startTime":"0","endTime":"0","summary":"ProKidney Corp. will participate in the Guggenheim Healthcare Innovation Conference in Boston on November 12, 2025, where senior management will take part in a fireside chat. The presentation will be available via live webcast on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via GlobeNewswire  on October 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL7j3jkx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","BK4112","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU2210149790.SGD","BK4588","LU2210150020.SGD","PROK","LU2095319765.USD","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2576064399","title":"BRIEF-Prokidney Corp to sell Greensboro property for $19.1 million - SEC filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2576064399","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576064399?lang=en_us&edition=fundamental","pubTime":"2025-10-18 05:03","pubTimestamp":1760735039,"startTime":"0","endTime":"0","summary":"BRIEF-Prokidney Corp to sell Greensboro property for $19.1 million - SEC filingOct 17  - Prokidney Corp PROK.O:PROKIDNEY CORP - TO SELL GREENSBORO PROPERTY FOR $19.1 MILLION - SEC FILINGSource text: [ID:n0001193125-25-242565]Further company coverage: PROK.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VY33B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","BK4139"],"gpt_icon":0},{"id":"2576106157","title":"ProKidney Corp - to Sell Greensboro Property for $19.1 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2576106157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576106157?lang=en_us&edition=fundamental","pubTime":"2025-10-18 04:37","pubTimestamp":1760733467,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nFWN3VY33B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PROK"],"gpt_icon":0},{"id":"2575403214","title":"Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2575403214","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575403214?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:05","pubTimestamp":1760353507,"startTime":"0","endTime":"0","summary":"As U.S.-China trade tensions resurface, major stock indexes have posted significant weekly losses, highlighting the volatility in today's market. Despite this uncertainty, penny stocks—often smaller or newer companies—remain a relevant investment area for those seeking growth opportunities at lower price points. In this article, we explore three penny stocks that combine solid financial foundations with potential for impressive returns.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/discovering-potential-izea-worldwide-and-2-other-top-penny-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/discovering-potential-izea-worldwide-and-2-other-top-penny-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4217","BK4173","UUU","ERAS","BK4551","CURI","BK4084","SELF.AU","DDL","BK4113","PSHG","BK4021","BK4157","WDH","BK4139","IZEA","LCUT","BK4077","BK4180","BK4539","BABB","BK4509","SELF","BK4134","PROK","CINT","BK4108","BK4209"],"gpt_icon":0},{"id":"2572041546","title":"SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC","url":"https://stock-news.laohu8.com/highlight/detail?id=2572041546","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572041546?lang=en_us&edition=fundamental","pubTime":"2025-10-02 23:32","pubTimestamp":1759419120,"startTime":"0","endTime":"0","summary":"Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/02/SPAC.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/02/SPAC.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/ipos/25/10/47997701/spac-king-chamath-palihapitiya-retail-investors-stay-away-new-spac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/ipos/25/10/47997701/spac-king-chamath-palihapitiya-retail-investors-stay-away-new-spac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4551","TSYW.SI","BK4547","AEXA","SQQQ","MNQmain","BK4187","LU0505663152.USD","BK4139","SPCE","PROK","TQQQ","QLD","BK4585","USJW.SI","BK4166","BK4549","ISBC","BK4168","NVIW.SI","PSQ","BK4079","BK4211","BK4154","BK4535","BK4588","QID","BK4564","USAW.SI","CLOV","BK4562","BK4561",".IXIC","IE00BD6J9T35.USD","NQmain"],"gpt_icon":1},{"id":"2567903851","title":"ProKidney Leads Our Trio Of Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2567903851","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567903851?lang=en_us&edition=fundamental","pubTime":"2025-09-12 19:04","pubTimestamp":1757675098,"startTime":"0","endTime":"0","summary":"As the U.S. stock market reaches record highs, bolstered by inflation data that fuels hopes for interest rate cuts, investors are keenly exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, continue to present intriguing possibilities despite their seemingly outdated label. These stocks can offer significant growth potential when backed by strong financials and solid fundamentals, making them a noteworthy consideration for those looking to uncover...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/prokidney-leads-our-trio-of-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prok/prokidney/news/prokidney-leads-our-trio-of-promising-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PBYI","BK4509","MAPS","TBTC","BK4526","BK7090","BK4150","TUYA","BK4551","PSHG","WDH","BK4505","TTI.AU","BK4539","DDL","BK4180","BK4113","BABB","BK4021","BK4209","BK4139","PROK","BK4173","BK4179","TTI","BK4023","LCUT"],"gpt_icon":0},{"id":"2562669743","title":"ProKidney Corp. to Participate in Citi Biopharma Back to School and Morgan Stanley Global Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562669743","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562669743?lang=en_us&edition=fundamental","pubTime":"2025-08-27 19:35","pubTimestamp":1756294508,"startTime":"0","endTime":"0","summary":"ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, announced that its senior management team will participate in the Citi Biopharma Back to School Conference in Boston on Wednesday, September 3, 2025. The event will include a fireside chat scheduled for 10:30 am ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief via GlobeNewswire  on August 27, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL5k0VgM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0162691827.USD","LU2360032135.SGD","LU0130517989.USD","PROK","IE00BKPKM429.USD","LU0098860793.USD","LU0170899867.USD","BK4112","LU0130102774.USD","BK4566","LU2095319765.USD","BK4207","LU2125154935.USD","LU0052756011.USD","LU0980610538.SGD","BK4139","IE00B64PRP62.GBP","LU1267930227.SGD","LU0648001328.SGD","LU2236285917.USD","LU2456880835.USD","LU0320765646.SGD","BK4559","IE00BSNM7G36.USD","LU0128525689.USD","LU2462157665.USD","LU0314104364.USD","LU1791807156.HKD","LU0072461881.USD","LU2417539215.USD","IE00B3QW5Z07.USD","LU1162221912.USD","LU0106831901.USD","LU1366192091.USD","LU0310800965.SGD","LU2125154778.USD","LU1244550221.USD","LU1244550577.SGD","LU1201861249.SGD","BK4588","NDAQ","BK4585","BK4534","LU2210149790.SGD","BK4504","IE00BGHQF748.EUR","LU1244550494.USD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2559629122","title":"ProKidney Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $221.000K","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629122","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629122?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:05","pubTimestamp":1755029144,"startTime":"0","endTime":"0","summary":"ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47073740/prokidney-q2-eps-0-13-beats-0-15-estimate-sales-221-000k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ProKidney Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $221.000K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK"],"gpt_icon":0},{"id":"2559629118","title":"ProKidney Announces Positive Phase 2 REGEN-007 Results and FDA Alignment for Accelerated Approval Pathway of Rilparencel","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629118","media":"Reuters","labels":["productRelease","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629118?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:03","pubTimestamp":1755028993,"startTime":"0","endTime":"0","summary":"ProKidney Corp., a company specializing in cell therapeutics for chronic kidney disease, has announced the positive topline results from its Phase 2 REGEN-007 study. The study demonstrated a 78% improvement in the eGFR slope in Group 1 after treatment with rilparencel. Full results from the REGEN-007 study are set to be submitted as a late-breaking clinical trial at the American Society of Nephrology 2025 Kidney Week. Additionally, the FDA has confirmed the use of the eGFR slope as a surrogate endpoint for accelerated approval of rilparencel in patients with type 2 diabetes and advanced chronic kidney disease. The ongoing Phase 3 PROACT 1 study will serve as both the accelerated approval and confirmatory study, with topline data expected in the second quarter of 2027. ProKidney continues to enroll patients for this study and aims to bring a novel treatment option to address the unmet clinical needs in this patient population.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL9V8LMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","BK4112","BK4139","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","PROK","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ"],"gpt_icon":0},{"id":"2551198381","title":"UBS Adjusts ProKidney Price Target to $8 From $4, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2551198381","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551198381?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:51","pubTimestamp":1752587512,"startTime":"0","endTime":"0","summary":"ProKidney (PROK) has an average rating of overweight and mean price target of $5.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PROK"],"gpt_icon":0},{"id":"2551216211","title":"BRIEF-Prokidney Announces Alignment With The FDA On The Accelerated Approval Pathway For Rilparencel","url":"https://stock-news.laohu8.com/highlight/detail?id=2551216211","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551216211?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:24","pubTimestamp":1752582298,"startTime":"0","endTime":"0","summary":"BRIEF-Prokidney Announces Alignment With The FDA On The Accelerated Approval Pathway For RilparencelJuly 15 (Reuters) - ProKidney Corp PROK.O:PROKIDNEY ANNOUNCES ALIGNMENT WITH THE FDA ON THE ACCELERA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nTUABVWTJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"gpt_icon":1},{"id":"2551164871","title":"ProKidney Corp. Secures FDA Alignment for Accelerated Approval Pathway of Rilparencel in Advanced CKD and Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164871","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164871?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:44","pubTimestamp":1752579845,"startTime":"0","endTime":"0","summary":"WINSTON-SALEM, N.C., July 15, 2025 - ProKidney Corp. , a leading late clinical-stage cellular therapeutics company, has announced a significant regulatory milestone with the U.S. Food and Drug Administration . The FDA has confirmed alignment on the accelerated approval pathway for ProKidney's rilparencel, an autologous cellular therapy aimed at preserving kidney function in patients with advanced chronic kidney disease  and type 2 diabetes. The ongoing Phase 3 PROACT 1 study, which has enrolled nearly half of the required patients, will serve as the basis for the accelerated approval analysis using the slope of estimated glomerular filtration rate  as a surrogate endpoint. Topline data to support the application for accelerated approval is anticipated in Q2 2027. This alignment marks a critical step forward for ProKidney in addressing the needs of patients with high unmet clinical and societal demands.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL3gKps:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PROK"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":47,"code":"91000000","status":"200"}]}}